Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02647892 · ClinicalTrials.gov registry record · Phase 4
Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia
A Phase 4 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02647892: Clinical Trial Phase 4 study, sponsored by University of Nebraska.
NCT02647892 is a Phase 4 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02647892, a Phase 4 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.
Primary Outcome
numeric pain scale
Interventions
- DRUG sodium bicarbonate
- DRUG lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-01-08 |
| Est. Completion | 2021-11-05 |
| Phase | Phase 4 |
Why NCT02647892 stopped before completion
NCT02647892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which sodium bicarbonate is the first listed.
NCT02647892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02647892 about?
NCT02647892 is a clinical study titled "Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia". The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.
What is the current status of trial NCT02647892?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2016-01-08. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT02647892?
The interventions under investigation include: sodium bicarbonate (DRUG), lidocaine (DRUG).
Who is sponsoring clinical trial NCT02647892?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02647892's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI